Skip to main content
SpringerLink
Log in

Influence of Neoadjuvant Therapy on Poor Long-Term Outcomes of Postoperative Complications in Patients with Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study

  • Thoracic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Postoperative complications have a negative impact on overall survival after esophagectomy because systemic inflammation may induce residual cancer cell growth. A solution that could suppress micrometastasis is neoadjuvant therapy; however, to date, no study has shown that neoadjuvant therapy suppresses proliferation of cancer cells due to postoperative complications after esophagectomy. The aim of this study is to investigate the influence of neoadjuvant therapy on poor long-term outcomes of postoperative complications in patients with esophageal carcinoma.

Patients and Methods

In total, 431 patients who underwent esophagectomy for esophageal squamous cell carcinoma were included in this study. We investigated the relationship between complications, such as pneumonia, and long-term oncologic outcomes with and without neoadjuvant therapy.

Results

Among the patients, the 3-year overall survival (OS) rate was 69.5% and the disease-free survival (DFS) rate was 59.0%. The patients were categorized into two groups: the neoadjuvant therapy (+) group (n = 217) and neoadjuvant therapy (−) group (n = 214). Among patients not undergoing neoadjuvant therapy, patients with pneumonia or pyothorax had significantly poorer OS and DFS than patients without these complications. However, among patients undergoing neoadjuvant therapy, there were no significant differences in long-term outcomes, regardless of presence of complications. On multivariate analysis, pneumonia (p = 0.003), pyothorax (p < 0.001), and chylothorax (p = 0.002) were identified as predictors of death in the neoadjuvant therapy (−) group.

Conclusion

The negative impact of postoperative complications on long-term prognoses can be reduced by performing neoadjuvant therapy in patients with esophageal carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260:259–66.

    Article  PubMed  Google Scholar 

  2. Mariette C, Taillier G, Van Seuningen I, et al. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg. 2004;78:1177–83.

    Article  PubMed  Google Scholar 

  3. Pennathur A, Luketich JD, Landreneau RJ, et al. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Ann Thorac Surg. 2008;85:1930–7.

    Article  PubMed  Google Scholar 

  4. Booka E, Takeuchi H, Nishi T, et al. The impact of postoperative complications on survivals after esophagectomy for esophageal cancer. Medicine (Baltimore). 2015;94:e1369.

    Article  Google Scholar 

  5. Takeuchi M, Kawakubo H, Mayanagi S, et al. Postoperative pneumonia is associated with long-term oncologic outcomes of definitive chemoradiotherapy followed by salvage esophagectomy for esophageal cancer. J Gastrointest Surg.  2018;22:1881–9.

    Article  PubMed  Google Scholar 

  6. Kataoka K, Takeuchi H, Mizusawa J, et al. Prognostic impact of postoperative morbidity after esophagectomy for esophageal cancer. Ann Surg. 2017;265:1152–7.

    Article  PubMed  Google Scholar 

  7. Baba Y, Yoshida N, Shigaki H, et al. Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma: a retrospective single-institution study. Ann Surg. 2016;264:305–11.

    Article  PubMed  Google Scholar 

  8. Saeki H, Tsutsumi S, Tajiri H, et al. Prognostic significance of postoperative complications after curative resection for patients with esophageal squamous cell carcinoma. Ann Surg. 2017;265:527–33.

    Article  PubMed  Google Scholar 

  9. Takeuchi M, Takeuchi H, Kawakubo H, et al. Perioperative risk calculator predicts long-term oncologic outcome for patients with esophageal carcinoma. Ann Surg Oncol. 2018;25:837–43.

    Article  PubMed  Google Scholar 

  10. Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2011;19:68–74.

    Article  PubMed  Google Scholar 

  11. Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part II and III. Esophagus. 2017;14:37–65.

    Article  Google Scholar 

  12. Sobin L, Gospodarowicz MWC (eds). TNM classification of malignant tumours. 7th ed. New York: Wiley-Liss; 2009.

    Google Scholar 

  13. Japan Esophageal Society. Japanese classification of esophageal cancer, 11th edition: part I. Esophagus. 2017;14:1–36.

    Article  Google Scholar 

  14. Kaburagi T, Takeuchi H, Kawakubo H, et al. Clinical utility of a novel hybrid position combining the left lateral decubitus and prone positions during thoracoscopic esophagectomy. World J Surg. 2013;38:410–8.

    Article  Google Scholar 

  15. Matsuda S, Takeuchi H, Kawakubo H, et al. Clinical outcome of transthoracic esophagectomy with thoracic duct resection: number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct. Medicine. 2016;95:e3839.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240:205–13.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Takeuchi H, Saikawa Y, Oyama T, et al. Factors influencing the long-term survival in patients with esophageal cancer who underwent esophagectomy after chemoradiotherapy. World J Surg. 2009;34:277–84.

    Article  Google Scholar 

  18. Eto K, Hiki N, Kumagai K, et al. Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications. Gastric Cancer. 2018;21:703–9.

    Article  CAS  PubMed  Google Scholar 

  19. Rizk NP, Bach PB, Schrag D, et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004;198:42–50.

    Article  PubMed  Google Scholar 

  20. Okamura A, Takeuchi H, Matsuda S, et al. Factors affecting cytokine change after esophagectomy for esophageal cancer. Ann Surg Oncol. 2015;22:3130–5.

    Article  PubMed  Google Scholar 

  21. Ogura M, Takeuchi H, Kawakubo H, et al. Clinical significance of CXCL-8/CXCR-2 network in esophageal squamous cell carcinoma. Surgery. 2013;154:512–20.

    Article  PubMed  Google Scholar 

  22. Chen MF, Chen PT, Chen WC, et al. The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression. Oncotarget. 2016;7:7913–24.

    PubMed  PubMed Central  Google Scholar 

  23. Nakamura K, Kato K, Igaki H, et al. Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study). Jpn J Clin Oncol. 2013;43:752–5.

    Article  PubMed  Google Scholar 

  24. Hirao M, Ando N, Tsujinaka T, et al. Influence of preoperative chemotherapy for advanced thoracic oesophageal squamous cell carcinoma on perioperative complications. Br J Surg. 2011;98:1735–41.

    Article  CAS  PubMed  Google Scholar 

  25. Kranzfelder M, Gertler R, Hapfelmeier A, et al. Chylothorax after esophagectomy for cancer: impact of the surgical approach and neoadjuvant treatment: systematic review and institutional analysis. Surg Endosc. 2013;27:3530–8.

    Article  PubMed  Google Scholar 

  26. Mc Cormack O, Zaborowski A, King S, et al. New-onset atrial fibrillation post-surgery for esophageal and junctional cancer: incidence, management, and impact on short- and long-term outcomes. Ann Surg. 2014;260:772–8.

    Article  PubMed  Google Scholar 

  27. Ancona E, Cagol M, Epifani M, et al. Surgical complications do not affect longterm survival after esophagectomy for carcinoma of the thoracic esophagus and cardia. J Am Coll Surg. 2006;203:661–9.

    Article  PubMed  Google Scholar 

  28. Rutegard M, Lagergren P, Rouvelas I, et al. Surgical complications and long-term survival after esophagectomy for cancer in a nationwide Swedish cohort study. Eur J Surg Oncol. 2012;38:555–61.

    Article  CAS  PubMed  Google Scholar 

  29. Low DE, Alderson D, Cecconello I, et al. International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg. 2015;262:286–94.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank Kumiko Motooka, a staff member at the Department of Surgery in Keio University School of Medicine, for help in preparation of the manuscript.

Funding

Yuko Kitagawa reports personal fees from ETHICON PART OF JOHNSON AND JOHNSON FAMILY OF COMPANIES, grants from KYOWA HAKKO KIRIN CO., LTD, personal fees from Medtronic Japan Co., Ltd., outside the submitted work.

Author information

Authors and Affiliations

  1. Department of Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan

    Masashi Takeuchi MD, Hirofumi Kawakubo MD, PhD, Shuhei Mayanagi MD, PhD, Tomoyuki Irino MD, PhD, Kazumasa Fukuda PhD, Rieko Nakamura MD, PhD, Norihito Wada MD, PhD, Hiroya Takeuchi MD, PhD & Yuko Kitagawa MD, PhD

  2. Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan

    Hiroya Takeuchi MD, PhD

Authors
  1. Masashi Takeuchi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hirofumi Kawakubo MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuhei Mayanagi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomoyuki Irino MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazumasa Fukuda PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rieko Nakamura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Norihito Wada MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hiroya Takeuchi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yuko Kitagawa MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hirofumi Kawakubo MD, PhD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplemental Figure 1

Kaplan–Meier curves for disease-free survival (DFS) associated with pneumonia in the (A-1) neoadjuvant therapy (+) group and (A-2) neoadjuvant therapy (−) group; Kaplan–Meier curves for cancer-specific survival (CSS) associated with pneumonia in the (B-1) neoadjuvant therapy (+) group and (B-2) neoadjuvant therapy (−) group. Red and blue lines indicate groups with and without pneumonia, respectively (TIFF 332 kb)

Supplementary material 2 (DOCX 34 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takeuchi, M., Kawakubo, H., Mayanagi, S. et al. Influence of Neoadjuvant Therapy on Poor Long-Term Outcomes of Postoperative Complications in Patients with Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study. Ann Surg Oncol 26, 2081–2089 (2019). https://doi.org/10.1245/s10434-019-07312-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-019-07312-z

Search

Navigation